Wagner N, Engel P, Tedder T F
Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, MA.
J Immunol. 1993 Jun 1;150(11):4887-99.
Cell-cell adhesive interactions involve numerous receptor/ligand interactions that play a crucial role in the development of immune function. Engagement of multiple cell-surface molecules on B lymphocytes generates intracellular signals through a tyrosine kinase-dependent pathway that activates cell-surface adhesion receptors and thereby induces homotypic cell-cell adhesion. Homotypic adhesion is mediated in part through LFA-1/ICAM-1 and other heretofore unknown adhesion receptors. In this study, evidence of a regulatory role for CD45 in the induction of homotypic adhesion is suggested. A new mAb (HAB-1) was developed that inhibits homotypic adhesion in B cell lines induced through MHC class I and class II, CD19, CD20, CD21, CD40, and Leu-13 cell-surface molecules. Although binding of this mAb strongly inhibited cell-surface Ag-induced homotypic adhesion at mAb concentrations as low as 0.1 microgram/ml, it exhibited no effect on homotypic adhesion induced by phorbol esters. Binding of the HAB-1 mAb to lymphocytes altered the pattern of cellular protein tyrosine phosphorylation, but did not have a global inhibitory effect on cell activation because it did not have major effects on the growth of mitogen-activated lymphocytes. Immunoprecipitation studies revealed that the HAB-1 mAb identified an epitope present on all isoforms of CD45. The HAB-1 mAb may identify a unique epitope of CD45 because this mAb had a unique staining pattern when assessed by indirect immunofluorescence staining. The HAB-1 mAb was similar to some other CD45 mAb that have the capacity to amplify CD2-induced proliferation of blood lymphocytes. However, only 1 of 12 other anti-CD45 mAb tested had a similar inhibitory effect on adhesion. Homotypic adhesion of lymphocytes may therefore be governed by a regulatory system of cell-surface molecules that generate positive and negative signals that either trigger adhesion or, like CD45, directly down-regulate adhesion. This highlights the significance of adhesive events that result from surface molecules being engaged by their natural ligands during lymphocyte activation.
细胞间黏附相互作用涉及众多受体/配体相互作用,这些相互作用在免疫功能发育中起着关键作用。B淋巴细胞上多种细胞表面分子的结合通过酪氨酸激酶依赖性途径产生细胞内信号,该途径激活细胞表面黏附受体,从而诱导同型细胞间黏附。同型黏附部分通过淋巴细胞功能相关抗原-1/细胞间黏附分子-1及其他迄今未知的黏附受体介导。在本研究中,提示了CD45在诱导同型黏附中具有调节作用的证据。一种新的单克隆抗体(HAB-1)被研制出来,它能抑制通过主要组织相容性复合体I类和II类、CD19、CD20、CD21、CD40和白细胞表面抗原13细胞表面分子诱导的B细胞系中的同型黏附。尽管该单克隆抗体在低至0.1微克/毫升的浓度下就能强烈抑制细胞表面抗原诱导的同型黏附,但它对佛波酯诱导的同型黏附没有影响。HAB-1单克隆抗体与淋巴细胞的结合改变了细胞蛋白酪氨酸磷酸化模式,但对细胞激活没有全局性抑制作用,因为它对有丝分裂原激活的淋巴细胞生长没有重大影响。免疫沉淀研究表明,HAB-1单克隆抗体识别出存在于CD45所有同工型上的一个表位。HAB-1单克隆抗体可能识别出CD45的一个独特表位,因为通过间接免疫荧光染色评估时,该单克隆抗体具有独特的染色模式。HAB-1单克隆抗体与其他一些能够增强CD2诱导的血液淋巴细胞增殖的CD45单克隆抗体相似。然而,在测试的其他12种抗CD45单克隆抗体中,只有1种对黏附具有类似的抑制作用。因此,淋巴细胞的同型黏附可能受细胞表面分子调节系统的控制,该系统产生正信号和负信号,这些信号要么触发黏附,要么像CD45一样直接下调黏附。这突出了淋巴细胞激活过程中表面分子与其天然配体结合所导致的黏附事件的重要性。